Nexttobe AB FI Dnr 18-16023 Att: Verkställande direktren Delgivning nr 2 Bredgränd 14 753 20 Uppsala . 3DJH RI Sanktionsavgift enligt lagen (1991:980) om handel med finansiella instrument . Finansinspektionens beslut . Finansinspektionen beslutar att Nexttobe AB (556624-5717) ska betala

Nexttobe AB ska betala en sanktionsavgift på 25 000 kronor för att för sent ha anmält till Finansinspektionen att dess innehav av aktier och

Hitta adress på karta, kontaktinfo, nyckeltal och befattningar. Nexttobe AB. 556624-5717 (Uppsala). Översikt · Telefonnummer · Adresser · Styrelse och koncern · Verklig huvudman · Nyckeltal · Kreditupplysning. Nu kan du Prior to joining us, from April 2011 until December 2015, Mr. Heimer was a partner at Nexttobe AB, a family office/investment company focused on the Swedish Juridiskt namn: Nexttobe AB. Org.nr: 5566245717. Bolagsform: Privat aktiebolag.

Gå med för att Company profile page for Nexttobe AB including stock price, company news, press releases, executives, board members, and contact information NXT2B is a fully privately owned venture capital company. We are able to make fast decisions on any investment opportunities since we do not require any external capital. The NXT2B team has proven experience in commercialization of innovative projects. Nexttobe AB. Contact.

AllgoHolding AB Bioimics AB Bluefish Pharmaceuticals AB Delta Projects AB Hansa Biopharma AB Lokon Pharma AB Lumina Adhesives AB Navinci Diagnostics AB Q-linea AB Repos Pharma AB Scint-X AB Sweden Carnica Group AB Vivolux AB

Uppdatering: Februari 2020; Färna Invest AB 47,41 %, Nexttobe 29, In case of sufficient demand, the Company's largest shareholder Nexttobe AB ('Nexttobe') may also sell up to SEK 450 / $50 million of its stake (Uppdaterad) Nexttobe, som är storägare i bioteknikbolaget Hansa Medical, säljer 7 procent av i sitt innehav i Hansa Medical. Bengt Ågerups investmentbolag Nexttobe har avyttrat hela innehavet i läkemedelsföretaget Realtid Media AB Kjellberg Eriksson som representant för Nexttobe AB, Max Mitteregger som representant för Gladiator och Fredrik Bogren som representant för Uppsala, den 30 maj 2018 --- Oasmia Pharmaceutical AB (NASDAQ: OASM) meddelar idag att Nexttobe AB har förlängt sitt lån till bolaget.

Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden.

Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Nexttobe AB gick med vinst (2019) Nexttobe AB gick med vinst, 1 071 801 000 kr. Nexttobe AB minskade sin omsättning med -94,63% senaste räkenskapsåret.

Bolagsform: Privat aktiebolag. SNI-bransch: 86909 Andra öppna enheter för hälso- och sjukvård, utan läkare. Nexttobe AB. Org.nr: 556624-5717. Företag: Nexttobe AB. Adress: Bredgränd 14. SE-753 20 Uppsala. Besöksadress: Bredgränd 14. SE-753 20 Uppsala.
Jan pellegrini

29 Aug 2011 nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an agreement with a group of shareholders in Olink AB 3 Dec 2012 Consequently, Nexttobe AB's ownership increases from approximately 10.1 percent to approximately 17.4 percent of the shares and votes in We are leveraging our cutting-edge science to develop lifesaving and life altering therapies for patients with rare immunological diseases. 30 jul 2020 Både investmentbolaget Nexttobe och travstallet Zet:s bolag Brixton Medical AB ägdes tidigare holländska bolaget Lyftet Holding BV, ett 16 mar 2021 Nexttobe AB. FI Dnr 18-16023. Att: Verkställande direktören.

Angelica is the CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University. Angelica is within the field of immune, gene and cell therapy with a focus on cancer and autoimmune disease. In connection with the rights issue, Nexttobe AB has, in addition to its pro rata share, subscribed for 5,950,159 shares in accordance with the underwriting agreement entered into with the Company. Consequently, Nexttobe AB’s ownership increases from approximately 10.1 percent to approximately 17.4 percent of the shares and votes in Oasmia.
Cogo starzinger

james bond kvinnliga skadespelare
johannes gustavsson fotö
byta bankkontor inom handelsbanken
drogterapeut jobb
flygmekaniker lön dubai
vem far barnbidraget
storboda anstalt adress

Airway, breathing, and circulation are all vital for life, and each is required, in that order, for the next to be effective. Since its development, the mnemonic has

Nexttobe AB är ett ledande riskkapitalbolag som Tagged Nexttobe AB. Home · Nexttobe AB · Nyhetssvepet måndag 2 oktober. 2 oktober, 2017. Ett redaktionellt urval av dagens Life Science-nyheter De senaste Nexttobe AB - Hitta nyheter, ekonomiska siffror, kontaktuppgifter, nyckeltal, bokslut, styrelse, koncernträd och så mycket mer på bizzdo.se. Verksamheter som utövas av huvudkontor.

The shares comprised by the Share Sale are owned by Nexttobe AB ("Nexttobe"). Nexttobe currently holds 5,755,379 shares in Hansa Biopharma, representing approximately 12.5% of the total shares and 12.9% of total votes outstanding in Hansa Biopharma.

Angelica is within the field of immune, gene and cell therapy with a focus on cancer and autoimmune disease.

Bolagets VD är Erika Kjellberg Eriksson 59 år. På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m. Alltid uppdaterat. Nexttobe AB har 2 anställda och gjorde ett resultat på 1 071 801 KSEK med omsättning 99 KSEK under 2019.